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A B S T R A C T
Background
Colloid solutions are widely used in fluid resuscitation of critically ill patients. There are several choices of colloid and there is ongoing
debate about the relative effectiveness of colloids compared to crystalloid fluids.
Objectives
To assess the effects of colloids compared to crystalloids for fluid resuscitation in critically ill patients.
Search methods
We searched the Cochrane Injuries Group Specialised Register (searched 16March 2012), the Cochrane Central Register of Controlled
Trials 2011, issue 3 (The Cochrane Library), MEDLINE (Ovid) 1946 to March 2012, EMBASE (Ovid) 1980 to March 2012, ISI Web
of Science: Science Citation Index Expanded (1970 to March 2012), ISI Web of Science: Conference Proceedings Citation Index-
Science (1990 to March 2012), PubMed (searched 16 March 2012), www.clinical trials.gov and www.controlled-trials.com. We also
searched the bibliographies of relevant studies and review articles.
Selection criteria
Randomised controlled trials (RCTs) of colloids compared to crystalloids, in patients requiring volume replacement.We excluded cross-
over trials and trials in pregnant women and neonates.
Data collection and analysis
Two review authors independently extracted data and rated quality of allocation concealment. We analysed trials with a ’double-
intervention’, such as those comparing colloid in hypertonic crystalloid to isotonic crystalloid, separately. We stratified the analysis
according to colloid type and quality of allocation concealment.
Main results
We identified 74 eligible trials; 66 of these presented mortality data.
Colloids compared to crystalloids
Albumin or plasma protein fraction - 24 trials reported data on mortality, including a total of 9920 patients. The pooled risk
ratio (RR) from these trials was 1.01 (95% confidence interval (CI) 0.93 to 1.10). When we excluded the trial with poor-quality
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allocation concealment, pooled RR was 1.00 (95% CI 0.92 to 1.09). Hydroxyethyl starch - 21 trials compared hydroxyethyl starch
with crystalloids and included 1385 patients. The pooled RR was 1.10 (95% CI 0.91 to 1.32). Modified gelatin - 11 trials compared
modified gelatin with crystalloid and included 506 patients. The pooled RR was 0.91 (95% CI 0.49 to 1.72). (When the trials by
Boldt et al were removed from the three preceding analyses, the results were unchanged.) Dextran - nine trials compared dextran with
a crystalloid and included 834 patients. The pooled RR was 1.24 (95% CI 0.94 to 1.65).
Colloids in hypertonic crystalloid compared to isotonic crystalloid
Nine trials compared dextran in hypertonic crystalloid with isotonic crystalloid, including 1985 randomised participants. Pooled RR
was 0.91 (95% CI 0.71 to 1.06).
Authors’ conclusions
There is no evidence from RCTs that resuscitation with colloids reduces the risk of death, compared to resuscitation with crystalloids,
in patients with trauma, burns or following surgery. As colloids are not associated with an improvement in survival, and as they are
more expensive than crystalloids, it is hard to see how their continued use in these patients can be justified outside the context of RCTs.
P L A I N L A N G U A G E S U M M A R Y
Are colloids more effective than crystalloids in reducing mortality in people who are critically ill or injured?
Trauma, burns or surgery can cause people to lose large amounts of blood. Fluid replacement, giving fluids intravenously (into a vein)
to replace lost blood, is used to try to maintain blood pressure and reduce the risk of dying. Blood products, non-blood products
or combinations are used, including colloid or crystalloid solutions. Colloids are increasingly used but they are more expensive than
crystalloids. This review of trials found no evidence that colloids reduce the risk of dying compared with crystalloids.
B A C K G R O U N D
Fluid resuscitation for hypovolaemia is a mainstay of the med-
ical management of critically ill patients, whether as a result of
trauma, burns, major surgery or sepsis. Although some studies
(Bickell 1994) have suggested that the timing of volume replace-
ment deserves careful consideration, when it comes to selecting
the resuscitation fluid, clinicians are faced with a range of options.
At one level the choice is between a colloid or crystalloid solution.
Colloids are widely used, having been recommended in a number
of resuscitation guidelines and intensive care management algo-
rithms (Armstrong 1994; Vermeulen 1995).
The US Hospital Consortium Guidelines recommend that col-
loids are used in haemorrhagic shock prior to the availability of
blood products, and in non-haemorrhagic shock following an ini-
tial crystalloid infusion. However, a 1995 survey of US academic
health centres found that the use of colloids far exceeded even the
Hospital Consortium recommendations (Yim 1995). Surveys of
burn care in the US (Fakhry 1995) and in Australia (Victorian
DUAC 1991) found that the use of colloids for resuscitation var-
ied without a set pattern.
The choice of fluid has considerable cost implications. Volume re-
placement with colloids is considerably more expensive than with
crystalloids. Clinical studies have shown that colloids and crys-
talloids have different effects on a range of important physiolog-
ical parameters. Because of these differences, all-cause mortality
is arguably the most clinically relevant outcome measure in ran-
domised trials comparing the two fluid types.
Why it is important to do this review
Although there have been previous meta-analyses of mortality in
randomised trials comparing colloids and crystalloids (Bisonni
1991; Velanovich 1989), neither of these satisfy the criteria that
have been proposed for scientific overviews (Oxman 1994), and
they predate most of the trials that have been conducted using syn-
thetic colloids, and hypertonic crystalloid solutions. The purpose
of this systematic review is to identify and synthesise all available
unconfounded evidence of the effect on mortality in critically ill
patients of colloids compared to crystalloids for volume replace-
ment.
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O B J E C T I V E S
To assess the effects on mortality of using colloids compared to
crystalloids, during fluid resuscitation in critically ill patients.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Controlled trials in which participants were randomised to treat-
ment groups (colloid or control) on the basis of random alloca-
tion. As the comparison between fluid type was in terms of effects
on mortality, we excluded randomised cross-over trials.
Types of participants
Critically ill patients (excluding neonates and pregnant women)
who required volume replacement.We included patients whowere
critically ill as a result of trauma, burns, undergoing surgery, or
had other critical conditions such as complications of sepsis.
We excluded preoperative elective surgical patients.
Types of interventions
We considered the following colloids: dextran 70, hydroxyethyl
starches, modified gelatins, albumin or plasma protein fraction.
There is overlap between albumin given for volume replacement
and albumin given as a nutritional supplement, andmany patients
with a critical illness have low serum albumin. Where the trial
was of total parenteral nutrition with or without albumin, we
excluded it. We included trials where the albumin was given as
part of volume replacement guided by colloid osmotic pressure or
albumin levels.
The control group received crystalloid (isotonic or hypertonic)
for fluid replacement. We included trials in which both groups
received blood.
We excluded trials of fluids used for other purposes. For exam-
ple, we excluded trials of pre-loading in preparation for elective
surgery, and trials in patients undergoing fluid loading before car-
diopulmonary bypass.
Types of outcome measures
The principal outcome measure was mortality from all causes,
assessed at the end of the follow-up period scheduled for each trial.
Search methods for identification of studies
We did not restrict the search for trials by date, language or pub-
lication status.
Electronic searches
We searched the following electronic databases:
• Cochrane Injuries Group Specialised Register (searched 16
March 2012);
• the Cochrane Central Register of Controlled Trials 2011,
issue 3 (The Cochrane Library);
• MEDLINE (Ovid) 1946 to March, Week 1, 2012;
• EMBASE (Ovid) 1980 to March 2012;
• ISI Web of Science: Science Citation Index Expanded
(1970 to March 2012);
• ISI Web of Science: Conference Proceedings Citation
Index-Science (1990 to March 2012);
• PubMed (searched 16 March 2012);
• National Research Register (2006, Issue 4).
All search strategies are listed in full in Appendix 1.
Searching other resources
We searched the reference lists of all relevant papers and pub-
lished review articles. We also contacted known trialists to iden-
tify any further studies that we may have missed. We searched the
online trials registers www.clinical trials.gov and www.controlled-
trials.com for published and unpublished studies.
Data collection and analysis
The Injuries Group Trials Search Coordinator ran the electronic
database searches, collated the results and removed duplicates be-
fore passing the list of citations to the lead review author (PP) for
screening.
Selection of studies
Two review authors independently examined the list of citations
for eligibility. We obtained full-text copies of all relevant records
and independently assessed whether each met the pre-defined in-
clusion criteria. We resolved disagreement by discussion.
Assessment of risk of bias in included studies
We scored allocation concealment as described by Higgins 2011,
assigning ’high risk of bias’ to poorest quality and ’low risk of bias’
to best quality (the presence of solutions in identical containers was
only taken to mean adequate concealment if the fluid containers
were used sequentially).
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• Low risk of bias = trials deemed to have taken adequate
measures to conceal allocation (i.e. central randomisation;
serially numbered, opaque, sealed envelopes; or other description
that contained elements convincing of concealment).
• Unclear = trials in which the authors either did not report
an allocation concealment approach at all or reported an
approach that did not fall into one of the other categories.
• High risk of bias = trials in which concealment was
inadequate (such as alternation or reference to case record
numbers or to dates of birth).
We collected but did not score information on blinding and loss
to follow-up.
Data synthesis
As a result of comments on the previous version of this review, we
have stratified trials by type of fluid rather than type of original
injury.
We calculated risk ratios (RRs) and 95% confidence intervals (CI)
for each study using a fixed-effect model. We then inspected each
comparison visually for evidence of heterogeneity and performed
a Chi2 test. If there was no evidence of heterogeneity (visually or
with a P value < 0.1) the trials were pooled within each type of
fluid, but not combined between type of fluid.
Sensitivity analysis
We then excluded trials with allocation concealment judged as
inadequate and repeated the calculations.
The editorial group is aware that a clinical trial by Professor
Joachim Boldt has been found to have been fabricated (Boldt
2009). As the editors who revealed this fabrication point out (
Reinhart 2011; Shafer 2011), this casts some doubt on the ve-
racity of other studies by the same author. All Cochrane Injuries
Group reviews that include studies by this author have therefore
been edited to show the results with this author’s trials included
and excluded. Readers can now judge the potential impact of trials
by this author on the conclusions of the review.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
We identified 74 trials meeting the inclusion criteria for study
design, participants and interventions. We were able to obtain
mortality data for 66 of these. We have reported details of the
included trials in the ’Characteristics of included studies’ table.
Reasons for exclusion of trials were: the use of a cross-over design,
testing a resuscitation algorithm, giving the control group oral
fluids, the interventionbeingdirected to themaintenance of serum
albumin levels, for haemodilution, for fluid loading and for the
reduction of intracranial pressure (see ’Characteristics of excluded
studies’ table).
Of the 66 trials with data on deaths, the quality of allocation
concealment was adequate in 13 trials and unclear in most of the
others.
There were 65 comparisons of colloids and crystalloids (add-on
colloid), 12 comparisons of colloid in hypertonic crystalloid with
isotonic crystalloid and three comparisons of colloid with hyper-
tonic crystalloid.
Risk of bias in included studies
In general, the design of studies was not well reported. This is
reflected in the number of unclear scores given for allocation con-
cealment. We also collected information on blinding and loss to
follow-up. Blinding was not well reported and loss to follow-up
was generally small. The characteristics for each trial are listed in
the ’Characteristics of included studies’ table.
Effects of interventions
Colloids compared to crystalloids
Albumin or plasma protein fraction
Twenty-four trials reported data on mortality, including a total of
9920 patients. The pooled RR was 1.01 (95% CI 0.93 to 1.10).
When trials by Boldt were removed, the results were unchanged
(RR 1.01; 95%CI 0.93 to 1.10). When we excluded the trial with
poor-quality allocation concealment (Lucas 1978), pooled RRwas
1.00 (95% CI 0.92 to 1.09).
Hydroxyethyl starch
Twenty-one trials compared hydroxyethyl starch with crystalloids,
including a total of 1385 randomised patients. The pooled RRwas
1.10 (95% CI 0.91 to 1.32). When trials by Boldt were removed,
the results were unchanged.
Modified gelatin
Eleven trials comparedmodified gelatinwith crystalloid, including
a total of 506 randomised patients. The pooled RRwas 0.91 (95%
CI 0.49 to 1.72). When trials by Boldt were removed, the results
were unchanged.
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Dextran
Nine trials compared dextran with a crystalloid, including a total
of 834 randomised patients. The pooled RR was 1.24 (95% CI
0.94 to 1.65).
Colloids in hypertonic crystalloid compared to
isotonic crystalloid
One trial compared albumin and hypertonic saline with isotonic
crystalloid. TheRR of death was 0.50 (95%CI 0.06 to 4.33). One
trial compared 6% hydroxyethyl starch 130/0.4 and hypertonic
saline with Ringer’s lactate. The RR of death was 0.25 (95% CI
0.03 to 2.15).
Nine trials compared dextran in hypertonic crystalloid with iso-
tonic crystalloid, including 1879 randomised patients. The pooled
RR was 0.91 (95% CI 0.79 to 1.06).
Colloids in isotonic crystalloid compared to
hypertonic crystalloid
Three trials compared colloids in isotonic crystalloid with hyper-
tonic crystalloid. In two of these, where the colloid was either
gelatin or starch, there were no deaths in either group. In the re-
maining trial, with 38 patients, there was a RR of death of 7.00
(95% CI 0.39 to 126.93) for use of colloid, based on three deaths
in the treatment group and none in the control group.
Sensitivity analysis
When all trials authored by Professor Boldt (Boldt 1986; Boldt
1993; Boldt 2001; Lang 2001; Lang 2003) were excluded conclu-
sions remain unchanged.
D I S C U S S I O N
This systematic review synthesises the evidence from RCTs com-
paring colloid and crystalloid fluid resuscitation across a wide vari-
ety of clinical conditions. The review has been updated and exten-
sively revised to take into account the comments made since it was
first published. In particular, several commentators pointed out
that it is inappropriate to combine effect estimates from studies
of different colloids. For example, it was argued that large molec-
ular weight colloids such as hydroxyethyl starch may be better re-
tained in the vascular compartment than albumin and gelatins,
and would therefore be more likely to show a favourable effect
on mortality (Gosling 1998). In response to these concerns, the
review has been stratified by type of colloid. However, the pooled
RRs fail to show a mortality benefit for resuscitation with any type
of colloid.
There was a trend towards a favourable effect on mortality for col-
loids in hypertonic crystalloid, compared to isotonic crystalloids.
Nevertheless, the results are compatible with the play of chance.
Common to all meta-analyses, this systematic review may have in-
cluded studies whose interventions and patient characteristics are
sufficiently incomparable that the calculation of a summary effect
measure may be questioned. The resuscitation regimen differed
between trials. Some trials randomised participants to an initial
quantity of colloid or crystalloid, and then proceeded with some
form of standard resuscitation for all participants. Other trials re-
suscitated with the allocated fluid to pre-determined end points,
either resuscitation end points, or in the case of trauma, until cor-
rective surgery. In addition, the type of colloid or crystalloid, the
concentration, and the protocol to determine the quantity of fluid
varied. Despite these differences, all participants were in need of
volume replacement, and we believe that this variation in the in-
tervention would have an impact on the size of the effect, rather
than on its direction.
As regards the effects of albumin versus crystalloid, most of the in-
formation (as indicated by the weighting in themeta-analysis) was
provided by the SAFE (Saline versus Albumin Fluid Evaluation)
trial (SAFE2004). The SAFE trial used central randomisationwith
a minimisation algorithm to ensure balance on known potential
confounders. Blinding was assured through the use of specially de-
signed masking cartons and specially designed and manufactured
administration sets. The trial authors report that the effectiveness
of the blinding was confirmed in a formal study before the trial was
initiated. In brief, this was a well-conducted, high-quality trial.
There were 726 deaths (20.9%) in the albumin-treated group and
729 deaths (21.1%) in the saline-treated group (RR of death 0.99;
95% CI 0.91 to 1.09). Although even this large trial was unable
to confirm or refute the possibility of a modest benefit or harm
from albumin, it has provided some reassurance that any hazard
from albumin, if indeed there is any, is unlikely to be as extreme as
was suggested by the results from the previously published (now
here updated) meta-analysis of much smaller trials. The pooled
RR for death with albumin in this updated meta-analysis is now
1.02 (95% CI 0.93 to 1.11). It is important to note that the effect
estimate from the SAFE trial is entirely consistent with the results
of previous trials of albumin in hypovolaemia and there is no sig-
nificant heterogeneity (I2 = 0%, P = 0.46).
The results of this updated meta-analysis have important policy
implications. There is still no evidence that colloids are superior to
crystalloids as a treatment for intravascular volume resuscitation in
critically ill patients. Importantly, the SAFE trial also provided no
evidence of any other clinical advantages from using albumin. It
also debunked the belief, from pathophysiological inference, that
very large volumes of crystalloid must be administered to reach
the same resuscitation end points as can be achieved using much
smaller volumes of colloid. In the SAFE trial, the ratio of albumin
administered to saline administered was approximately 1:1.4. Col-
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loids, in particular albumin, are considerably more expensive than
crystalloids, and albumin is a blood product and so carries at least
a theoretical infectious disease risk. The economic opportunity
cost of ongoing colloid use, particularly albumin use, is likely to
be considerable and for this reason its ongoing use in this context
is unjustified.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is no evidence from RCTs that resuscitation with colloids,
instead of crystalloids, reduces the risk of death in patients with
trauma, burns or following surgery. As colloids are not associated
with an improvement in survival, and further, colloids are consid-
erably more expensive than crystalloids, it is hard to see how their
continued use outside the context of RCTs in subsets of patients
of particular concern, can be justified.
Implications for research
Future trials may need to concentrate on specific subgroups of
patients to identify people who may benefit from colloids rather
than crystalloids.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Boldt 1986
Methods RCT, using sealed opaque envelopes
Information on allocation concealment was obtained on contact with the authors
Blinding and loss to follow-up not mentioned
Participants 55 patients undergoing elective aorta-coronary bypass surgery
Exclusion criteria: ejection fraction < 50% and LVEDP > 15 mmHg
Interventions 1. 300 mL 20% Human albumin solution (n = 15)
2. 500 mL 3% HES (n = 13)
3. 500 mL 3.5% Gelatin (n = 14)
4. No colloid (n = 13)
Outcomes Haemodynamic variables were measured
Deaths not reported
Notes Follow-up until discharge from ICU
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Boldt 1993
Methods RCT, allocation concealment by sealed opaque envelopes (information from author)
Blinding and loss to follow-up not mentioned
Participants 75males undergoing elective aortocoronary bypass grafting, who had a pulmonary capillary
WP < 5 mmHg after induction of anaesthesia
Interventions 1. 5% Albumin (n = 15)
2. 6% HES, mean molecular weight 450,000 (n = 15)
3. 6% HES, mean molecular weight 200,000 (n = 15)
4. 3.5% Gelatin (n = 15)
5. No colloid (n = 15)
Fluid used through operation and on intensive care postoperatively
Outcomes Deaths not reported, author confirmed there were no deaths
Notes Follow-up to 1 day
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Boldt 1993 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Boldt 2001
Methods RCT, using a closed-envelope system
Participants 100 patients undergoing major abdominal surgery
Interventions 1. Ringer’s lactate (n = 25)
2. 6% HES, mean molecular weight 200 kDa, degree of substitution 0.5 (n = 25)
3. 6% HES, mean molecular weight 130 kDa, degree of substitution 0.4 (n = 25)
4. 4% Modified fluid gelatin, molecular weight 35 kDa (n = 25)
Outcomes Deaths
Orthostatic problems
Haemodynamics and laboratory data
Fluid input and output
Costs
Notes Follow-up period unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Boutros 1979
Methods RCT (“randomly divided”), method of allocation concealment not described
Blinding not mentioned
No loss to follow-up
Participants 24 people undergoing major operative procedures on the abdominal aorta
Interventions 1. Albumin in 5% dextrose (n = 7)
2. 5% Dextrose and Ringer’s lactate (n = 8)
3. 5% Dextrose in 0.45% saline (n = 9)
Allocated fluids were used on admission to ICU, following surgery, guided by PAWP.Whole
blood also given if clinically needed
Outcomes Deaths reported
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Boutros 1979 (Continued)
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Bowser-Wallace 1986
Methods Quasi-RCT, allocation by alternation
Blinding not mentioned
No loss to follow-up
Participants Admitted for burns of 30% or more
Age range 5 months to 21 years
Excluded if already given more than half calculated daily requirement before reaching
hospital
Interventions 1. 2 mL/kg/%burn Ringer’s lactate over 24 hours, then 0.5 mL plasmanate/kg/%burn
over 24 hours plus 5% dextrose (n = 19)
2. 2 mL/kg/%burn hypertonic lactated saline over 24 hours, then 0.6 mL/kg/%burn
hypertonic lactated saline over 24 hours plus oral Haldane’s solution (n = 19)
IV fluids stopped at 48 hours (n = 19)
Outcomes Deaths reported
Fluid and electrolytes given, weight, haematocrit
Notes Follow-up to 5 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
Brunkhorst 2008
Methods Multicentre, RCT
Blinding not mentioned
Use of a 2 x 2 factorial, open label study design
Participants Critically ill patients with severe sepsis or septic shock of at least 18 years of age. Excluded if
onset of symptoms commenced > 24 hours before admission to the ICU, if the symptoms
commenced > 12 hours after onset in the ICU or if patient had received more than 1000
mL of HES in the 24 hours before randomisation
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Brunkhorst 2008 (Continued)
Interventions
Outcomes Deaths reported at 28 and 90 days. 90-day mortality rate was cited as it marked the end of
the follow-up period
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Bulger 2011
Methods Double-blind RCT
Participants 15 years or older with hypovolaemic shock (< 70 mmHg SBP or SBP 71 mmHg to < 90
mmHg and HR < 108 bpm
Interventions 1. 7.5% saline per 6% dextran (n = 220)
2. 0.9% saline (n = 376)
Outcomes Primary outcome: 28-day survival
Secondary outcomes: fluid and blood requirements, ARDS, MODS and nosocomial in-
fections
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk All care providers, investigators and patients remained blinded to
the treatment assignment
Chavez-Negrete 1991
Methods RCT, allocation by “random numbers”
Blinding not mentioned
No loss to follow-up
Participants Adults admitted to an emergency department with acute GI haemorrhage, SBP ≤ 90
mmHg for up to 1 hour and normal ECG
Excluded if pregnant or had renal, cardiac or neurological disease
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Chavez-Negrete 1991 (Continued)
Interventions 1. Initial infusion of 250 mL 7.5% saline/6% dextran 60 given IV (16 patients) or
intraosseous (n = 10)
2. Initial IV infusion of 250 mL Ringer’s lactate (n = 23)
Resuscitation continued with red cells, 0.9% saline and dextran 40 according to clinical
judgement
Outcomes Death
Haemodynamic variables
Notes Follow-up to 24 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Cifra 2003
Methods Quasi-RCT (allocation by alternation), allocation concealment not reported
Blinding not reported
No loss to follow-up
Participants 27 children with dengue shock syndrome
Exclusion criteria included: other severe infection, protein-deficient abnormalities, bleeding
diathesis, patients who have been given multiple plasma substitutes
Interventions 1. 6% Haes-Steril (n = 11)
2. Ringer’s lactate (n = 16)
1 patient from group 1 and 3 patients from group 2 were excluded because they needed
inotropic support and multiple plasma substitute
Outcomes Duration of control of shock
Recurrence of shock
Length of ICU stay
Death not reported as an outcome but they reported that 4 patients died
Notes Length of follow-up not reported but all outcomes were in hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Not used
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Cooper 2006
Methods Multicentre unblinded controlled trial with stratified block randomisation by centre and
mortality prediction at enrolment
Participants Patients with cutaneous thermal burns of at least 20% TBSA within 12 hours of injury
Interventions 1. Ringer lactate and 5% albumin (n = 19)
2. Ringer lactate (n = 23)
Outcomes Primary outcome was MODS
Mortality was reported
Notes The trial was suspended due to slow enrolment
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Patients were allocated to study groups with
stratified randomisation with a computer-
generated randomisation list and sequen-
tially numbered sealed, opaque envelopes
Dawidson 1991
Methods RCT, allocation by drawing a card from a deck
Blinding not mentioned
No loss to follow-up
Participants Adults undergoing elective abdominal aortic surgery
No exclusions mentioned
Interventions 1. 3% Dextran 70 in Ringer’s lactate (n = 10)
2. IV Ringer’s lactate (n = 10)
Fluid used during and for 24 hours after operation, guided by haemodynamic variables
Outcomes Death
Volume transfused, weight change, haemodynamic variables
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
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Dehne 2001
Methods RCT, allocation by sealed envelope assignment
Participants 60 male patients (of ASA physical status 1 or 2) scheduled for middle ear surgery
Interventions 1. Ringer’s lactate solution (n = 15)
2. 6% HES: molecular weight 200 kDa, degree of substitution 0.5 (n = 15)
3. 6% HES: molecular weight 200 kDa, degree of substitution 0.60 to 0.66 (n = 15)
4. 6% HES: molecular weight 450 kDa, degree of substitution 0.7 (n = 15)
Outcomes Deaths not stated but ’all’ patients discharged 10 to 14 days after surgery; therefore no
deaths
Central venous pressure
Urine output
Blood osmolality
Urine osmolality
Notes Follow-up 2 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Du 2011
Methods Randomised controlled study
Participants Participants had confirmed diagnosis of severe acute pancreatitis. Patients were included
within 72 hours after the onset of symptoms
Interventions 1. 6% HES 130/0.4 (n = 20)
2. Ringer’s lactate (n = 21)
Outcomes Primary outcome was intra-abdominal pressure. They also reported in-hospital mortality,
organ complications, inflammatory markers and fluid requirement
Notes Patients were excluded if they died within 72 hours after admission
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Dubin 2010
Methods RCT
Participants Patients with severe sepsis
Interventions 1. 6% HES 130/0.4 (n = 12)
2. Normal saline (n = 13)
Outcomes Sublingual microcirculation
Notes Data on mortality are not clear from the report
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk sealed enveloped were used
Eleftheriadis 1995
Methods Patients “randomizedly distributed”
Blinding not mentioned
Unable to assess loss to follow-up
Participants Participants were undergoing coronary artery bypass surgery
Interventions 1. 6% HES
2. 3.5% Gelatin
3. Ringer’s lactate
Allocated fluid was used in the postoperative period only guided by mean arterial pressure
Outcomes Deaths were not reported
Haemodynamic variables
Notes Follow-up period unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Ernest 1999
Methods RCT, allocation concealment not described
No blinding
No loss to follow-up mentioned
Participants Patients with a clinical diagnosis of sepsis
Interventions 1. 5% Albumin (n = 9)
2. 0.9% Saline (n = 9)
Volume of infusion guided by PAWP
Outcomes Haemodynamic variables and volume measurements
Deaths not reported
Notes Follow-up to immediately after infusion
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Evans 1996
Methods Quasi-randomised trial, allocation by day of the week
Blinding not mentioned
No loss to follow-up
Participants Aged≥ 16 years, admitted with trauma to an emergency centre within 2 hours after injury,
only crystalloid as a pre-hospital infusion
Excluded if had underlying illness likely to affect clotting
Interventions 1. IV Haemaccel (n = 11)
2. IV Ringer’s lactate (n = 14)
Fluid was used until vital signs were stable
Outcomes Deaths from author
Clotting variables
Notes Follow-up period unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
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Evans 2003
Methods RCT, allocation concealment not reported
Blinding methods not reported
Loss to follow-up not reported
Participants 55 patients undergoing primary unilateral total hip replacement
Exclusion criteria: pre-existing defect in platelet function or on aspirin that could not be
stopped for 2 weeks prior to the operation
Interventions 1. 4.5% Albumin (n = 13)
2. Gelofusine (n = 14)
3. Haemaccel (n = 14)
4. 0.9% Saline (n = 14)
Outcomes Haemostatic parameters
Death not reported
Notes Length of follow-up not reported but all outcomes were in-hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Fries 2004
Methods RCT, patients “randomly” received crystalloid or colloids
Method of allocation concealment not reported
Blinding not reported
Loss to follow-up not reported
Participants 60 patients undergoing knee replacement surgery
Exclusion criteria: contraindication for regional anaesthesia, known allergies or haemostatic
disorders
Interventions 1. HES (n = 20)
2. Modified gelatin (n = 20)
3. Ringer’s solution (n = 20)
Groups 1 and 2 also received a basis of Ringer’s solution infusion
Outcomes Coagulation parameters
Death not reported
Notes Length of follow-up not reported but all outcomes were in-hospital measures
Risk of bias
Bias Authors’ judgement Support for judgement
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Fries 2004 (Continued)
Allocation concealment (selection bias) Unclear risk Unclear
Gallagher 1985
Methods RCT, method of allocation concealment not described. Author contacted - allocation con-
cealment by computerised system - patient details were entered before treatment assign-
ment was revealed
Blinding not mentioned
No loss to follow-up
Participants Patients after coronary artery bypass graft surgery
Exclusion criteria: patients with significant left main coronary artery stenosis, poor left
ventricular function or poor pulmonary function
Interventions 1. IV 5% albumin (n = 5)
2. IV 6% HES (n = 5)
3. IV Ringer’s lactate (n = 5)
Fluid used from admission to ICU post operation, guided by PAWP. RBC given if needed
Outcomes Deaths were not reported. Author contacted and confirmed that there were no deaths in
any group
Haemodynamic data
Notes Follow-up to 1 day
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Goodwin 1983
Methods RCT, assigned by “random numbers table”, method of allocation concealment unclear
Blinding not mentioned
No loss to follow-up
Participants 79 previously healthy young adults admitted with burns
No exclusion criteria reported
Interventions 1. 2.5% Albumin in Ringer’s lactate (n = 40)
2. Ringer’s lactate (n = 39)
Fluids on day 1 guided by haemodynamic variable. On day 2, given at 0.3 to 0.5 mL/kg/
%burn, then 5% dextrose
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Goodwin 1983 (Continued)
Outcomes Deaths reported
Pulmonary oedema
Infections
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Grundmann 1982
Methods RCT, method of allocation concealment unclear
Blinding not mentioned
No loss to follow-up
Participants 20 people undergoing partial gastrectomy
The average age was 50 years (range 19 to 84 years)
No exclusion criteria reported
Interventions 1. Colloid group received human albumin solution (n = 14)
2. Details of crystalloid were not reported (n = 6)
Allocated fluid was continued for 4 days after operation
Outcomes Deaths reported
Volumes of fluid given
Haemodynamic variables
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Guo 2003
Methods RCT, allocation concealment not reported
Blinding not reported
No loss to follow-up reported
Participants 42 patients undergoing elective cytoreductive surgery for ovarian cancer
Exclusion criteria: preoperative anaemia, allergic response to HES or perioperative admin-
istration of cardiovascular agents
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Guo 2003 (Continued)
2 patients randomised but excluded because of use of cardiovascular agents
Interventions 1. Ringer’s lactate (n = 20)
2. 6% HES (n = 20)
Outcomes Splanchnic perfusion
Death not reported but in results authors mentioned that “all patients were discharged”
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Hall 1978
Methods Quasi-RCT (participants were stratified by age, extent of burn and aetiology, and then
allocated by alternation)
Blinding not mentioned
No loss to follow-up
Participants Burns covering > 10% of the body surface (for children), and > 15% of the body surface
(for adults)
No exclusions mentioned
Interventions 1. 120 mL/%burn IV 6% dextran 70 in 0.9% saline over 48 hours plus oral water or
IV 5% dextrose for ’metabolic requirements’ (n = 86)
2. 4 mL/kg/%burn IV Ringer’s lactate over 24 hours, then 10% of initial body weight
of fluid over 24 hours plus oral water (n = 86)
Outcomes Death
Fluid given, haemodynamic variables
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
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Hartmann 1993
Methods RCT, method of allocation unclear
Blinding not mentioned
No loss to follow-up
Participants Adults undergoing major abdominal surgery
Exclusion criteria: cardiorespiratory dysfunction, uraemia, diabetes, taking steroids, anti-
coagulants or diuretics
Interventions 1. IV Dextran 70 in saline (concentration not given) with 2.5% dextrose (n = 15)
2. IV Saline (concentration not given) with 2.5% dextrose (n = 14)
Both groups given red cells, plasma, dextran 70 and crystalloids during the operation as
decided by the clinician. Postoperative fluids according to the trial group guided by tissue
oxygen tension to the end of resuscitation
Outcomes Death not reported
Fluid given, haemodynamic variables
Notes Follow-up to 7 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
James 2011
Methods RCT
Double-blind
Participants Patients with blunt or penetrating trauma requiring more than 3 L volume resuscitation
(blunt and penetrating trauma patients were randomised separately)
Interventions 1. HES 130/0.4, penetrating trauma (n = 36)
2. 0.9% Saline, penetrating trauma (n = 34)
3. HES 130/0.4, blunt trauma (n = 22)
4. 0.9% Saline, blunt trauma (n = 23)
Outcomes Primary outcomes were the volumes of first fluid needed in the first 24 hours, and normal
GI function by day 5
Notes Although mortality at 30 days was a safety measure, the authors did not report data on
mortality for each group
Risk of bias
Bias Authors’ judgement Support for judgement
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James 2011 (Continued)
Allocation concealment (selection bias) Low risk Plastic bags with concealed label were randomly selected and placed
sequentially in a warming cabinet
Jelenko 1978
Methods RCT, method of allocation concealment unclear
Blinding not mentioned
No loss to follow-up
Participants 19 people with burns covering more than 20% of body surface
Interventions 1. 12.5% Albumin in hypertonic saline (240 mEq/L sodium, 120 mEq/L chloride,
120 mEq/L lactate) (n = 7)
2. Hypertonic saline (240 mEq/L sodium, 120 mEq/L chloride, 120 mEq/L lactate) (n
= 5)
3. Ringer’s lactate (n = 7)
Allocated fluid was used, guided by haemodynamic variables, to the end of resuscitation
Outcomes Deaths reported
Haemodynamic variables
Notes Follow-up to end of resuscitation
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Karanko 1987
Methods RCT, description of allocation procedure unclear
Blinding not mentioned
No loss to follow-up
Participants 32 adult men scheduled for coronary artery bypass surgery
Exclusion criteria: LVEF < 40%, abnormal lung function
Interventions 1. 6% Dextran 70 (n = 14)
2. Ringer’s lactate (n = 18)
Allocated fluid was used to the end of resuscitation
Outcomes Deaths reported
Haemodynamic variables
Pulmonary oedema
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Karanko 1987 (Continued)
Notes Follow-up 2 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Lang 2001
Methods RCT, using a closed-envelope system
Participants 42 patients scheduled for elective major abdominal surgery
Interventions 1. Ringer’s lactate (n = 21)
2. 6% HES, molecular weight 139 kDa, degree of substitution 0.4 (n = 21)
Outcomes Deaths
Haemodynamics and laboratory data
Tissue oxygenation
Volume input and output
Notes Follow-up period unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Lang 2003
Methods RCT, allocation concealment not clearly reported (“closed envelope system”)
Blinding method not reported (“...treatment in the ICU was performed by physicians who
were blinded to the study”)
Participants 36 patients undergoing elective major abdominal surgery
Exclusion criteria: myocardial failure, renal insufficiency, severe pulmonary disease, liver
dysfunction, diabetes mellitus, steroid therapy, pre-existing viral or bacterial infection and
known allergic reactions to starch preparations
Interventions 1. 6% HES (n = 18)
2. Ringer’s lactate (n = 18)
Additional crystalloid solutions were supplied to equalise insensible fluid loss or as a solvent
for drugs in group 1
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Lang 2003 (Continued)
Outcomes Pro- and anti-inflammatory cytokines
All patients survived
Notes Length of follow-up not reported but all outcomes were in-hospital measures
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Ley 1990
Methods RCT, method of allocation concealment unclear
Assessment of chest x-ray blinded
No loss to follow-up
Participants 21 people undergoing coronary artery bypass grafting or valve surgery
Interventions 1. 6% Hetastarch up to 1.5 L then 5% plasma protein fraction (n = 11)
2. 0.9% Saline (n = 10)
Allocated fluid was used for postoperative fluid resuscitation
Outcomes Deaths were not reported
Pulmonary and peripheral oedema
Haemodynamic variables
Notes Follow-up to discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Lowe 1977
Methods RCT, allocation by sealed envelopes
Blinding not mentioned
No loss to follow-up
Participants Participants with serious trauma
Interventions 1. 25% Albumin in Ringer’s lactate (n = 77)
2. Ringer’s lactate (n = 94)
Allocated fluid was used throughout the pre- and intraoperative period
30Colloids versus crystalloids for fluid resuscitation in critically ill patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lowe 1977 (Continued)
Outcomes Deaths reported
Notes Follow-up to 5 days postoperatively. Data on the 30 participants with chest injuries who
were left out of the Lowe 1977 report, but included in Moss 1981, have been included in
the meta-analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Lu 2012
Methods Randomised controlled study
Participants 42 patients with septic shock
Interventions 1. Ringer’s lactate (n = 20)
2. HES 130/0.4 (n = 22)
Outcomes Mortality, fluid replacement, use of vasoactive drugs and inflammatory markers
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Lucas 1978
Methods RCT, randomisation was based on the last digit of each patient’s case number
Participants 52 seriously injured patients
Interventions 1. Standard resuscitation regimen (’balanced electrolyte’, blood, fresh frozen plasma)
plus salt-poor albumin, maximum 150 g during surgery and 150 g/day for the next 5 days
(n = 27)
2. Standard resuscitation regimen as above (n = 25)
Outcomes Deaths reported in some patients
Notes In the final report of 94 randomised patients deaths were not reported. However, in this
preliminary report of 52 injured patients deaths were reported
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Lucas 1978 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
Maitland 2005
Methods RCT, open label, random allocation was assigned by the use of sealed cards
No loss to follow-up
Participants 159 children with severe malaria and metabolic acidosis
Exclusion criteria: pulmonary oedema, oedematous malnutrition or papilloedema
Interventions Severe acidosis
1. 4.5% Albumin (n = 23)
2. 0.9% Saline (n = 26)
Moderate acidosis
1. 4.5% Albumin (n = 33)
2. 0.9% Saline (n = 35)
3. Control (n = 33)
Outcomes Reduction in base deficit
Neurological sequelae
Death reported
Notes Length of follow-up not reported but all outcomes were in-hospital measures
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Maitland 2011
Methods 2 stratum multicentre open, RCT
Participants Children aged between 60 days and 12 years, with severe febrile illness, randomly assigned
within 2 strata (stratum A was children with severe febrile illness and impaired perfusion
but without severe hypotension; stratum B was children with severe hypotension)
Interventions Children were randomly allocated to rapid volume replacement over the course of 1 hour
with either:
1. 20 mL 5% Human albumin solution per kg body weight (n = 1063)
2. 20 mL 0.9% Saline solution per kg body weight (n = 1063)
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Maitland 2011 (Continued)
Outcomes Mortality at 4 weeks after randomisation
Notes Children (n = 1044) assigned to no treatment were not included in the analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Trial numbers kept inside opaque, sealed envelopes.
Opened in numerical order by clinician
Mattox 1991
Methods Quasi-randomised, allocation by alternation
Double-blind
2 patients excluded from the analysis as code of fluid lost
Participants Participants were pre-hospital trauma victims attended to by emergency personnel within
1 hour of injury, with SBP ≤ 90 mmHg, ≥ 16 years. 72% of participants had sustained
penetrating trauma
Interventions 1. 250 mL Dextran 70 in 7.5% saline (n = 211)
2. 250 mL Ringer’s lactate, saline or plasmalyte (n = 211)
Allocated fluid was for initial pre-hospital resuscitation only
Outcomes Deaths reported
Notes Follow-up to hospital discharge or transfer
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
Mazher 1998
Methods Patients “randomized”
Blinding of carers by use of pharmacy-prepared solutions
No loss to follow-up
Participants Patients undergoing elective coronary artery surgery
Exclusion criteria: age > 75 years, ejection fraction < 35%, creatinine > 135 µmol/L, ACE
inhibitors
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Mazher 1998 (Continued)
Interventions 1. 5 mL/kg Polygeline (n = 10)
2. 5 mL/kg 7.2% Saline (n = 10)
Allocated fluid given postoperatively over 1 hour. All patients subsequently receive polyge-
line and RBCs
Outcomes Haemodynamic variables
Death
Notes Follow-up to discharge from ICU
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
McIntyre 2008
Methods A feasibility RCT
Participants Patients with early septic shock defined with at least 2 systemic inflammatory response
syndrome criteria, infectious source and persistent hypotension after > 1 L of crystalloid
fluid
Interventions 1. Normal saline (n = 19)
2. Pentastarch (n = 21)
Outcomes Primary outcomes were feasibility measures for the pilot RCT. ICU and 28-day mortality
were also reported
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Only the designated research pharmacist at each institution was
aware of the treatment allocation for individual patients. Study
fluids were prepared and blinded ahead of time by the site research
pharmacist
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McNulty 1993
Methods RCT, method of allocation concealment not described
Blinding not mentioned
No loss to follow-up
Participants Patients following elective cardiopulmonary bypass
Interventions 1. 5% Albumin and cell-saved blood (n = 14)
2. Plasmalyte and cell-saved blood (n = 14)
Allocated fluid used as part of fluid volume replacement
Outcomes Deaths not reported
Study was designed to look at the effect of protein infusion on the accuracy of a haematocrit
measuring device
Notes Length of follow-up unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Metildi 1984
Methods RCT
Blinding not mentioned
No loss to follow-up
Participants Participants were admissions to an ICU and a trauma unit with ARDS and established
pulmonary failure. Included both trauma and non-trauma patients
Interventions 1. 5% Salt-poor albumin (n = 20)
2. Ringer’s lactate (n = 26)
Allocated fluid was used throughout resuscitation, and if an operation was required the
allocated fluid was used for volume replacement before and during the operation
Outcomes Deaths reported
Haemodynamic variables
Notes Follow-up to discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
35Colloids versus crystalloids for fluid resuscitation in critically ill patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Modig 1983
Methods Quasi-RCT, allocation by admission date
Blinding not mentioned
No loss to follow-up
Participants Participants were trauma admissions to an emergency department with SBP < 70 mmHg.
Age range 20 to 58 years
Interventions 1. Dextran 70 in Ringer’s lactate (n = 12)
2. Ringer’s lactate (n = 11)
Allocated fluids were given as the initial resuscitation fluid on admission to the emergency
department, and continued as needed until after the 6th day when major reconstructive
surgery was undertaken
Outcomes Deaths reported
Development of ARDS
Notes Follow-up to definitive reconstructive surgery
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
Moretti 2003
Methods RCT, allocation concealment method not clearly reported (“Patients randomized...by using
a closed-envelope technique”)
Blinding method not clearly reported (“Researchers were unaware of the patient’s random-
ization”)
No loss to follow-up
Participants 90 adult patients undergoing major elective general, gynaecological, orthopaedic or uro-
logical surgery with an anticipated blood loss > 500 mL
Exclusion criteria: age < 16 years, coagulopathy, renal or hepatic dysfunction and congestive
heart failure
Interventions 1. Hetastarch-normal saline (n = 30)
2. Hetastarch-balanced salt (n = 30)
3. Ringer’s lactate (n = 30)
Outcomes Postoperative nausea and vomiting
Death not reported
Notes Follow-up to discharge
Risk of bias
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Moretti 2003 (Continued)
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Nagy 1993
Methods RCT, contact with author showed it was an open-label study
Blinding not mentioned
No loss to follow-up
Participants Participants were adult admissions to a trauma unit, with measurable SBP < 90 mmHg
Interventions 1. Pentastarch in 0.9% saline (n = 21)
2. Ringer’s lactate (n = 20)
Allocated fluid was used throughout resuscitation with the exception that colloid patients
received a maximum 4 L of pentastarch, after which Ringer’s lactate was given
Outcomes Deaths were not reported
Haemodynamic variables
Notes Follow-up to discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) High risk Inadequate
Ngo 2001
Methods RCT, opaque envelopes containing only treatment pack number
Participants 230 children with dengue shock syndrome
Interventions 1. Dextran 70 (n = 55)
2. 3% Gelatin (n = 56)
3. Ringer’s lactate (n = 55)
4. ’Normal’ saline (n = 56)
Outcomes Initial pulse recovery time
Occurrence of timing and subsequent episodes of shock
Decrease in haematocrit
Volume of fluid administered until recovery
Complications
No deaths in any group
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Ngo 2001 (Continued)
Notes Follow-up period unclear
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Nielsen 1985
Methods RCT, method of allocation concealment not described
Blinding not mentioned
No loss to follow-up
Participants 26 patients admitted for reconstructive surgery of the abdominal aorta
Interventions 1. Whole blood, crystalloid plus 80 g albumin on the day of the operation, and 20 g/
day for the next 3 days. Albumin given as 100 mL 20% human albumin solution (n = 13)
2. Whole blood and crystalloid, type not specified (n = 13)
Outcomes Deaths not reported
Author when contacted confirmed that there were no deaths in either group
Notes Length of follow-up 4 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Pockaj 1994
Methods RCT, allocation concealment unclear
Blinding not mentioned
Loss to follow-up: 18/54 in colloid group, 13/53 in saline group
Participants Participants required fluid resuscitation as a result of vascular leak syndrome associated with
interleukin-2 therapy for metastatic cancer
Interventions 1. 250 mL Bolus of 5% albumin in saline (n = 36 reported)
2. 250 mL Bolus of 0.9% normal saline (n = 40 reported)
Boluses guided by haemodynamic variables. Both groups also received 0.45% saline with
10 mmol/L KCl
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Pockaj 1994 (Continued)
Outcomes Deaths
Toxic effects of chemotherapy
Haemodynamic variables
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Prien 1990
Methods RCT
Blinding not mentioned
No loss to follow-up
Participants Participants were undergoing modified Whipple’s operation
Interventions 1. 10% HES in 0.9% saline plus plasma protein fraction if requirements > 20 mL/kg
(n = 6)
2. 20% human albumin solution (n = 6)
3. Ringer’s lactate (n = 6)
Allocated fluid was administered intraoperatively only
Outcomes Deaths
Intestinal oedema formation
Notes Follow-up period was unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Rackow 1983
Methods RCT, allocation concealment unclear
Blinding not mentioned
No loss to follow-up
Participants Participants were aged 54 to 97 years, and had any 1 of the following pre-determined
indicators of shock: SBP ≤ 90 mmHg, cardiac index < 2.2 L/minute/m2, serum arterial
lactate > 18 mg/dL and WP < 15 mmHg
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Rackow 1983 (Continued)
Interventions 1. 6% HES (n = 9)
2. 5% Albumin (n = 9)
3. 0.9% Saline (n = 8)
Allocated fluid was given as needed until the end of resuscitation
Outcomes Deaths reported
Fluid balance
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Rocha e Silva 1994
Methods RCT
Participants Participants were admissions to the emergency department, with SBP ≤ 90 mmHg and ≥
16 years of age
Interventions 1. 6% Dextran 70 in 7.5% saline
2. Ringer’s lactate
Allocated fluid was used for the first IV infusion only
Outcomes Death was the main outcome measure, but the data are unpublished
Notes Follow-up to 30 days. By April 1994, 125 patients had been entered into the study
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
SAFE 2004
Methods RCT. Randomisation by minimisation algorithm accessed through secure website
Participants Patients aged ≥ 18 years admitted to closed multidisciplinary ICUs in 16 tertiary hospitals
in Australia over 19-month period
Interventions 1. 4% Albumin (Albumex, CSL) (n = 3499)
2. Normal saline (n = 3501)
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SAFE 2004 (Continued)
Outcomes Death
Patients with new single- or multiple-organ failure
Mean number of days: in ICU, in hospital, onmechanical ventilation, on renal replacement
therapy
Notes Follow-up to 28 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Shah 1977
Methods RCT, allocation by sealed envelope
Blinding not mentioned
No loss to follow-up
Participants Patients with severe, multiple trauma and SBP < 90 mmHg. All patients were adults and
both sexes were included
Interventions 1. 5% Salt-poor albumin in Ringer’s lactate (n = 9)
2. Ringer’s lactate (n = 11)
Volume infused guided by physiological parameters
Outcomes Death reported
Haemodynamic variables
Notes Length of follow-up not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Shires 1983
Methods Patients ’assigned randomly’
Blinding not mentioned
No loss to follow-up
Participants People undergoing aortic reconstruction surgery
No exclusion criteria mentioned
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Shires 1983 (Continued)
Interventions 1. Plasmanate (n = 9)
2. Ringer’s lactate (n = 9)
Allocated fluid used guided by haemodynamic variables until the first postoperative morn-
ing. All patients then received 0.45% saline
Outcomes Pulmonary oedema
Haemodynamic variables
Death
Notes Follow-up to 2 days postoperative
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Sirieix 1999
Methods Patients “randomly assigned”
Blinding not described
2 patients excluded after randomisation due to arrhythmias on giving the fluid (both in
hypertonic saline group)
Participants Patients undergoing mitral valve repair
Exclusion criteria: LVEF < 0.4, systolic PAP > 50 mmHg, coagulation disorders, creatinine
> 150 mmoL/L, electrolyte imbalance, diabetes, previous atrial fibrillation lasting > 1 year
Interventions 1. 250 mL 7.2% Hypertonic saline, 6% HES (n = 8)
2. 250 mL 7.2% Hypertonic saline (n = 10)
3. 250 mL 6% HES (n = 8)
Fluid given over 15 minutes, 1 hour after admission to postoperative ICU
Outcomes Haemodynamic variables
Deaths reported
Side effects (severe hypotension: 1 patient in group 1 and 2 patients in group 2; arrhythmias:
1 patient in group 1, 3 patients in group 2 and 1 patient in group 3)
Notes Follow-up to discharge from hospital (all within 10 days)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Skillman 1975
Methods RCT, allocation concealment unclear
Blinding not mentioned
No loss to follow-up
Participants Participants were undergoing elective abdominal reconstructive surgery
Interventions 1. 25% Salt-poor albumin 1 g/kg and 5% albumin 1 L (n = 7)
2. Ringer’s lactate
Allocated fluid was given intraoperatively. All patients received crystalloids only for pre-
loading before surgery
Outcomes Deaths were not reported
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Tollofsrud 1995
Methods RCT, allocation by sealed envelopes
Blinding not mentioned
No loss to follow-up
Participants Participants were adults in need of volume replacement during and after coronary artery
bypass surgery
Interventions 1. Haemaccel (n = 10)
2. Dextran 70 (n = 10)
3. Albumin 40 (n = 10)
4. Ringer’s lactate (n = 10)
Allocated fluid was used throughout resuscitation
Outcomes Deaths reported
Fluid balance
Notes Follow-up to 48 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Tollofsrud 1998
Methods RCT, allocation by sealed envelope
Described as double blind
No loss to follow-up mentioned
Participants Patients with 3 vessel coronary artery disease undergoing elective coronary artery surgery
Exclusion criteria: LVEF<0.4, ventricular aneurysm, significant arrhythmia, diabetes, renal
failure, lung disease
Interventions 1. 4 mL/kg of 75 mg/mL hypertonic saline in dextran 70 60 mg/mL over 30 minutes
(n = 10)
2. Same volume and rate of isotonic saline (n = 10)
Fluid given just after surgery while still in operating theatre. Ringer’s lactate for additional
fluid
Outcomes Fluid balance
Haemodynamic variables
Deaths not reported
Notes Follow-up to 48 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Upadhyay 2004
Methods Open-label randomised trial, allocation by sealed envelope
No loss to follow-up mentioned
Participants 60 patients with septic shock aged 1 month to 12 years
Exclusion criteria: age < 1 month, multiorgan failure and immunodeficiency states
Interventions 1. Normal saline (n = 31)
2. Polymer from degraded gelatin in saline (n = 29)
Outcomes Haemodynamic data
Death reported
Notes Length of follow-up not reported but all outcomes were in-hospital measures
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Vassar 1990
Methods RCT, allocation concealment unclear
Double-blind study (solutions prepared in identical containers)
No loss to follow-up
Participants Participants were emergency department admissions with trauma and SBP < 80 mmHg
and ≥ 18 years of age
Exclusion criteria: pregnant women and people with pre-existing cardiac, hepatic or renal
disease
Interventions 1. 6% Dextran 70 in 7.5% saline (n = 23)
2. Ringer’s lactate (n = 24)
Allocated fluids were given as the initial resuscitation in the emergency department. Addi-
tional isotonic crystalloids (Ringer’s lactate) were given as needed
Outcomes Deaths reported
Haemodynamic variables
Notes Follow-up to hospital discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Vassar 1991
Methods RCT, allocation by randomised sequence of coded containers
Double-blind study
No loss to follow-up
Participants Participants were pre-hospital trauma cases undergoing helicopter transport to an emer-
gency centre, with SBP ≤ 100 mmHg and ≥ 18 years
Exclusion criteria: pre-existing cardiac renal, hepatic or neurological disease; peripheral
oedema
Interventions 1. 4.2% Dextran 70 in 7.5% saline or 6% dextran 70 in 7.5% saline (n = 83)
2. Ringer’s lactate (n = 83)
Fluids were given as the initial resuscitation fluid in the pre-hospital setting. Supplemental
isotonic fluids were given at the discretion of the flight nurses
Outcomes Deaths reported
Haemodynamic variables
Notes Follow-up to discharge. Allocation was to 4.2% dextran 70, to 6% dextran 70, or to
crystalloid; for the calculation of the summary effect measure, the 2 dextran groups were
combined
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Vassar 1991 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Vassar 1993a
Methods RCT, allocation concealed by random sequence of identical containers
Double-blind study
36 people excluded post randomisation as deemed not to have met eligibility criteria
No loss to follow-up
Participants Participants, who were undergoing ambulance transport to an emergency centre, SBP ≤
90 mmHg, ≥ 18 years
Exclusion criteria: asystolic; undergoing CPR; lack sinus complex on ECG; > 2 hours after
trauma; pregnant; pre-existing seizures; bleeding disorder; hepatic, cardiac or renal disease
Interventions 1. 6% Dextran 70 in 7.5% saline (n = 89)
2. 7.5% Saline (n = 85)
3. 0.9% Saline (n = 84)
Participants received 250 mL of the allocated fluid in the pre-hospital setting. Additional
isotonic crystalloids were given as needed
Outcomes Deaths reported
Haemodynamic variables
Trauma scores
Notes Follow-up was to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Vassar 1993b
Methods RCT, allocation concealed by sequential use of coded identical containers
Double-blind study
39/233 patients excluded as deemed not to meet eligibility criteria, unclear from which
groups
Participants Participants were pre-hospital trauma cases undergoing helicopter transport to an emer-
gency centre, SBP ≤ 100 mmHg, ≥ 18 years
Exclusion criteria: asystolic; undergoing CPR; lack sinus complex on ECG; > 2 hours after
trauma; pregnant; pre-existing seizures; bleeding disorder; hepatic, cardiac or renal disease
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Vassar 1993b (Continued)
Interventions 1. 12% Dextran 70 in 7.5% saline (n = 49)
2. 6% Dextran 70 in 7.5% saline (n = 50)
3. 7.5% Saline (n = 50)
4. Ringer’s lactate (n = 45)
Participants received 250 mL of the allocated fluid in the pre-hospital setting. Additional
isotonic crystalloids were given as needed
Outcomes Deaths reported
Haemodynamic variables
Trauma scores and neurological outcome scores
Notes Follow-up to hospital discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Verheij 2006
Methods RCT, allocation concealment by “the sealed envelope method”
Blinding method not reported
No loss to follow-up
Participants 67 patients with presumed hypovolaemia after cardiac and major vascular surgery
Exclusion criteria: age > 79 years and known anaphylactoid reaction to colloids
Interventions 1. Saline (n = 16)
2. Gelatin (n = 16)
3. HES (n = 16)
4. Albumin (n = 16)
Outcomes Haemodynamic data
Death not reported
Notes Length of follow-up not reported but all outcomes were in-hospital measures
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Virgilio 1979
Methods Allocation “by random number”
Blinding not mentioned
No loss to follow-up
Participants Participants were undergoing abdominal aortic surgery
Interventions 1. 5% Albumin (n = 15)
2. Ringer’s lactate (n = 14)
Allocated fluid was used during operation for maintenance of pre-defined physiological
parameters, and the resuscitation was continued with the allocated fluid until the day
following the operation. This was followed by 5% dextrose in half-normal saline, with
potassium chloride as needed
Outcomes Deaths reported
Notes Follow-up 2.5 weeks
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Wahba 1996
Methods Patients “randomly allocated”
Blinding not mentioned
2 patients excluded as they required reoperation for bleeding
Participants 22 adults in need of volume replacement following coronary artery bypass surgery
Exclusion criteria: abnormal left ventricular function, platelet active medication or heparin
Interventions 1. Haemaccel (n = 10)
2. Ringer’s lactate (n = 10)
Allocated fluid was used from the time of admission to ICU following operation, to the
end of resuscitation
Outcomes Deaths reported
Pulmonary oedema
Notes Follow-up to discharge
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Wills 2005
Methods RCT, allocation concealed by specially prepared cardboard containers
Method of blinding not mentioned
No loss to follow-up
Participants 512 children with dengue shock syndrome aged 2 to 15 years
Interventions Children with immoderately severe shock were randomised to the 3 interventions
1. Ringer’s lactate (n = 128)
2. 6% Dextran 70 (n = 126)
3. 6% HES 200/0.5 (n = 129)
Children with severe shock were randomised only to either of the 2 colloids interventions:
1. 6% Dextran 70 (n = 67)
2. 6% HES 200/0.5 (n = 62)
Outcomes Requirement for supplemental intervention with rescue colloid
Time taken to achieve initial cardiovascular stability
Time taken to achieve sustained cardiovascular stability
Volume required
Change in haematocrit
Days in hospital
1 death reported but not specified in which group
Notes Length of follow-up not clear
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Low risk Adequate
Woittiez 1997
Methods RCT, allocation concealment by sealed opaque envelopes
No information on blinding or loss to follow-up
Participants 60 patients who had developed hypoalbuminaemia (< 20 g/L) after major surgery
2 patients died after randomisation and before treatment started. They were excluded from
the analysis
Interventions 1. Saline (500 mL/24 hours) (n = 16)
2. 20% Albumin (300 mL/24 hours) (n = 15)
3. 10% HES (500 mL/24 hours) for 3 days (n = 27)
Aim was to restore COP
Outcomes Changes in fluid balance, serum albumin, COP and clinical signs of oedema were followed
daily
Death rates supplied by the author
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Woittiez 1997 (Continued)
Notes Length of follow-up unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Wu 2001
Methods RCT. No details given of randomisation method
Participants 41 adolescent or adult patients in emergency department suffering from shock
Interventions 1. 4% Modified fluid gelatin: succinated gelatin 40 g/L, sodium chloride 7 g/L, sodium
hydroxide 1.36 g/L (n = 18)
2. Ringer’s lactate (n = 16)
Outcomes Death
Haemodynamic variables
Notes Not intention-to-treat: 5 patients who received blood transfusion and 2 who had surgery
within the first hour of resuscitation were dropped from the analysis
Length of follow-up not clear
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Younes 1992
Methods Randomised “in a double blind fashion”
Blinding by use of similar bottles
No loss to follow-up
Participants Participants were emergency department admissions, SBP < 80 mmHg, ≥ 19 years
Exclusion criteria: pregnant, pre-existing cardiac or metabolic disease
Interventions 1. 6% Dextran 70 in 7.5% saline (n = 35)
2. 7.5% Saline (n = 35)
3. 0.9% Saline (n = 35)
Allocated fluid was for initial bolus of 250 mL, followed by isotonic crystalloids as needed
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Younes 1992 (Continued)
Outcomes Deaths reported
Fluid balance
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Younes 1994
Methods Trial conducted in a “double blind randomised fashion”
Blinding by use of coded, identical containers
Participants Participants were trauma admissions to the emergency department requiring treatment for
haemorrhagic hypovolaemia; all were over 15 years old
Exclusion criteria: pregnant, cardiac or renal failure, cardiac arrest on arrival
Interventions 1. 6% Dextran 70 in 7.5% saline (n = 101)
2. 0.9% Saline (n = 111)
Allocated fluid was for the first IV infusion only
Outcomes Deaths reported
Complications
Notes Follow-up period was 30 days
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Younes 1998
Methods RCT, allocation by sealed envelope
Blinding not mentioned
No apparent loss to follow-up
Participants Trauma patients SBP < 90mmHg admitted to the emergency department, with no previous
treatment
Interventions 1. 10% Pentastarch (n = 12)
2. 0.9% Saline (n = 11)
Fluid given in 250 mL boluses until systolic blood pressure > 100 mmHg
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Younes 1998 (Continued)
Outcomes Deaths reported
No complications reported in either group
Notes Follow-up to 24 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Zetterstrom 1981a
Methods The patients were randomly divided into 2 groups
Allocation concealment was by sealed opaque envelopes (information supplied by study
author)
Blinding not mentioned
No loss to follow-up
Participants Adults undergoing elective major abdominal surgery
Interventions 1. Standard volume replacement regimen (1 L dextran 70 then up to 4 units of RBC
with electrolyte, then whole blood or RBC with plasma; postoperative patients were given
crystalloids and whole blood) plus 20% human albumin solution 100 mL at end of
operation, 200 mL to 300 mL on same day, then 200 mL on first postoperative day, then
100 mL for next 3 days (n = 15)
2. Standard volume replacement regimen (as above) (n = 15)
Outcomes Deaths reported
Haemodynamic variables
Notes Length of follow-up unspecified
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
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Zetterstrom 1981b
Methods Patients were randomly divided into 2 groups
Allocation concealment was by sealed opaque envelopes (information supplied by study
author)
Blinding not mentioned
No loss to follow-up
Participants 18 patients who had undergone elective abdominal aortic surgery
No exclusions mentioned
Interventions 1. 5% Human albumin solution (n = 9)
2. Ringer’s lactate solution (n = 9)
Administration guided by pulmonary arterial occlusion pressure
Outcomes Deaths reported
Haemodynamic variables
Notes Follow-up to discharge from hospital
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Zhu 2011
Methods RCT
Participants 135 participants with severe sepsis
Interventions 1. 7.5% Hypertonic saline plus 6% HES 130/0.4 (n = 45)
2. Ringer’s lactate plus 6% HES 130/0.4 (n = 45)
3. Ringer’s lactate (n = 45)
Outcomes Biomarkers, fluid requirements, and MODS. Mortality was also reported
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
ACE: angiotensin-converting enzyme; ARDS: adult respiratory distress syndrome; ASA: American Society of Anesthesiologists; bpm:
beats per minute; COP: colloid osmotic pressure; CPR: cardiopulmonary resuscitation; GI: gastrointestinal; HES: hydroxyethyl
starch;HR: heart rate; ICU: intensive care unit; IV: intravenous; LVEDP: left ventricular end diastolic pressure; LVEF: left ventricular
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ejection fraction; MODS: multiple organ dysfunction score; PAP: pulmonary artery pressure; PAWP: pulmonary artery wedge
pressure; RBC: red blood cell; RCT: randomised controlled trial; SBP: systolic blood pressure; TBSA: total body surface area; WP:
wedge pressure.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Artru 1989 Intervention to control intracranial pressure not directed at fluid resuscitation
Bocanegra 1966 Study contained 2 quasi-randomised comparisons of colloid with glucose and plasma/saline with saline. In
both studies, the control solution was only given IV if the patient was in coma or shock. It was therefore not
a reasonable comparison of colloid and crystalloid
Boldt 1996 All groups received some colloid
Boldt 2007 Comparison was not between colloids and crystalloids, rather 2 different colloid solutions
Bothner 1998 Participants were having minor elective surgery, therefore not considered to be critically ill
Breheme 1993 Intervention directed at haemodilution, not at volume replacement
Bueno R 2004 The participants had elective surgery
Chin 2006 Participants were undergoing elective surgery, therefore not considered to be critically ill
Golub 1994 Albumin given solely as a nutritional supplement
Goslinga 1992 Intervention directed at haemodilution, not volume replacement
Green 2008 Article is a review
Greenhalgh 1995 Intervention directed at the maintenance of serum albumin levels, not for volume replacement
Hauser 1980 Cross-over trial
Ko 2007 Comparison of crystalloids and colloids as pre-loading solutions
Krasheninnikov 2007 Not an RCT
Lagonidis 1995 Intervention was pre-loading for coronary artery bypass surgery
Lange 2011 Article was a review
Lobo 2008 Experiment conducted on rabbits
Marhofer 1999 Trial of fluid for pre-loading before spinal anaesthesia
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Mittermayr 2007 Patients were undergoing elective surgery
Mittermayr 2008 Outcome was the change in concentration of tissue-type plasminogen activator
Morrison 2011 Study evaluated the effect of hypertonic saline in patients with blunt head injury
Niemi 2008 Solutions were used for pump priming
Nilsson 1980 Albumin given as a nutritional supplement
Oliviera 2002 The participants had sepsis
Paton-Gay 2007 The outcome was non-relevant to comparing crystalloids and colloids
Paul 2003 The participants had elective surgery
Rehm 2001 2 colloids (albumin and hetastarch) compared
Steinberg 1989 Cross-over trial
Tiryakioglu 2008 Patients were undergoing elective surgery and not considered critically ill. Also, the solutions were used as
priming solutions
Tseng 2008 Crystalloid and colloid treatment was not randomised
Valetova 2007 Patients were randomised depending upon their treatment not prior to treatment
van der Heijden 2009 The report did not provide separate data for the 3 arms that received colloids (gelatin 4%, hydroxyethyl
starch 6% and albumin 5%)
Vercueil 2006 Article is a review
Wilkes 2001 1 group received saline plus hetastarch, the other received ’balanced’ fluid plus hetastarch. Thus, each group
received both a colloid and a crystalloid. This conflicts with the purpose our review, which compares patients
who had 1 of these with patients who had the other
Woods 1993 This quasi-randomised trial looked at albumin supplementation in postoperative patients, with the aim of
maintaining the serum albumin. Since the main aim of giving albumin was not to replace volume, the study
was excluded
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Characteristics of ongoing studies [ordered by study ID]
CHEST Trial
Trial name or title Crystalloid Versus Hydroxyethyl Starch Trials (CHEST)
Methods Multicentre phase 3 RCT of fluid resuscitation
Participants 7000 patients in ICU requiring fluid resuscitation
Interventions 1. 6% HES (130/0.4)
2. Saline
Outcomes 90 days all-cause mortality
Starting date December 2009
Contact information John A Myburgh, The George Institute, Sydney, New South Wales, Australia
Notes NCT00935168
RASP trial
Trial name or title Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP)
Methods RCT
Participants 360 patients with severe sepsis or septic shock
Interventions 1. Ringer’s lactate
2. 4% Albumin
Outcomes 28 days all-cause mortality
Starting date May 2012
Contact information Juliano P Almeida, Cancer Institute of Sao Paulo, School of Medicine, University of Sao Paulo
Notes NCT01337934
The 6S trial
Trial name or title Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S)
Methods Multicentre, randomised, double-blinded trial with concealed allocation
Participants 800 patients with severe sepsis in 30 Scandinavian ICUs
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The 6S trial (Continued)
Interventions 1. 6% HES 130/0.4 in Ringer’s acetate
2. Ringer’s acetate
Outcomes The composite end point of 90-day mortality or end-stage kidney failure is the primary outcome measure
Starting date December 2009
Contact information Anders Perner, ICU, Rigshospitalet, University of Copenhagen
Notes NCT00962156
HES: hydroxyethyl starch; ICU: intensive care unit; RCT: randomised controlled trial.
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